A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease

Coleman, R. orcid.org/0000-0002-4275-1043, Aksnes, A-K., Naume, B. et al. (6 more authors) (2014) A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease. Breast Cancer Research and Treatment , 145 (2). pp. 411-418. ISSN 0167-6806

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2014. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Keywords: Breast cancer; Bone metastases; Alpha-emitter; Radiopharmaceutical; Radium-223 dichloride; Radiation therapy
Dates:
  • Published: June 2014
  • Published (online): 13 April 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 22 Nov 2016 09:15
Last Modified: 22 Nov 2016 09:15
Published Version: http://dx.doi.org/10.1007/s10549-014-2939-1
Status: Published
Publisher: Springer Verlag
Refereed: Yes
Identification Number: https://doi.org/10.1007/s10549-014-2939-1
Related URLs:

Share / Export

Statistics